Archive
-
Working Paper
Working Paper SeriesPricing for Medicine Innovation: A Regulatory Approach to Support Drug Development and Patient Access
Feb 2022
US regulators can step in to ensure drug pricing both supports patient access and drug development
-
Working Paper
Working Paper SeriesProfits, Innovation and Financialization in the Insulin Industry
Apr 2020
This paper considers the relationship between profits realized from higher insulin list prices, pharmaceutical innovation, and the financial structures of the three dominant insulin manufacturing companies, which set list prices.
-
Working Paper
Working Paper SeriesPrivate Equity Buyouts in Healthcare: Who Wins, Who Loses?
Mar 2020
Private equity firms have become major players in the healthcare industry. How has this happened and what are the results?